Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 587

recruiting
3 975
countries
28
conditions
2 109

10 388 trials match your criteria

Study on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years

Anxiety disorder

Not recruiting

Study on Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to Current Treatment

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Troriluzole

Study of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zolbetuximab

Plasma cell myeloma

Not recruiting

Study comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Thalassaemia

Not recruiting

Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years

Multiple sclerosis

Not recruiting

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Schizophrenia

Not recruiting

Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years

Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years

Study on 68Ga-NOTA-Anti-HER2 VHH1 for Cancer Patients with Brain Metastasis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Gout

Not recruiting

Study on Gout: Comparing Immediate vs. Delayed Use of Febuxostat for Patients with Acute Gout Attacks

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.